Customization: | Available |
---|---|
Powder: | Yes |
Customized: | Non-Customized |
Suppliers with verified business licenses
Audited by an independent third-party inspection agency
Product name | Livagen(Lys-Glu-Asp-Ala) |
CAS No. | N/A |
MF | C18H31N5O9 |
MW | 461.47 |
Functions
It is stated that Livagen (Lys-Glu-Asp-Ala) is a weakly hydrolyzed peptide. Peptide hydrolases of small intestine do not hydrolyze Livagen even to a small extent. Under in vitro conditions Livagen reduces glycil-L-leucinedipeptidase activity in small intestine by 50%.Livagen induced activation of ribosomal genes, decondensation of pericentromeric structural heterochromatin, and release of genes repressed due to age-related condensation of euchromatic regions in chromosomes. Our results indicate that Livagen causes de-heterochromatinization (activation) of chromatin, which is realized via modification of heterochromatin and heterochromatinized regions in chromosomes from old people.Livagen proved to be more efficient also as compared to well-known peptidase inhibitors such as puromycin, leupeptin, and D-PAM. The dose-inhibitory effect curves for Livagen and Epitalon were plotted; their IC50 equaled 20 and 500 microM, respectively.
Related products
Type | Product Name | Speafication | Standard |
Female hormones | Progesterone | 57-83-0 | USP39 |
Estriol | 50-27-1 | USP41 | |
Estrogen | 56-53-1 | USP41 | |
Estradiol benzoate | 50-50-0 | USP | |
β-ESTRADIOL | 50-28-2 | USP39 | |
Ethynyl estradiol | 57-63-6 | USP | |
Megestrol acetate | 595-33-5 | USP39 | |
17a-Hydroxyprogesterone caproate | 630-56-8 | USP | |
Oestradiol 17-heptanoate | 4956-37-0 | USP | |
Depofemin | 313-06-4 | USP37 | |
Pregnenolone | 145-13-1 | USP | |
Levonorgestrel | 797-63-7 | USP | |
Product name
|
CAS No.
|
β-Nicotinamide Mononucleotide (NMN)
|
1094-61-7
|
beta-Diphosphopyridine nucleotide (NAD)
|
53-84-9
|
Nicotinamide riboside chloride (NRC)
|
23111-00-4
|
Nicotinamide Ribose (NR)
|
1341-23-7
|
|
53-43
|
Extraction process: